58 related articles for article (PubMed ID: 20625979)
1. Disentangling incentives effects of insurance coverage from adverse selection in the case of drug expenditure: a finite mixture approach.
Munkin MK; Trivedi PK
Health Econ; 2010 Sep; 19(9):1093-108. PubMed ID: 20625979
[TBL] [Abstract][Full Text] [Related]
2. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
Saleh SS; Weller W; Hannan E
J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
[TBL] [Abstract][Full Text] [Related]
3. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
LaVange LM; Silverman HA
Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
[TBL] [Abstract][Full Text] [Related]
4. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
5. The Medicare Part D doughnut hole: effect on pharmacy utilization.
Sun SX; Lee KY
Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
[TBL] [Abstract][Full Text] [Related]
6. Adverse and Advantageous Selection in the Medicare Supplemental Market: A Bayesian Analysis of Prescription drug Expenditure.
Li Q; Trivedi PK
Health Econ; 2016 Feb; 25(2):192-211. PubMed ID: 25504934
[TBL] [Abstract][Full Text] [Related]
7. Assessing the impact of coverage gaps in the Medicare Part D drug benefit.
Hudson N
Find Brief; 2008 Apr; 11(3):1-3. PubMed ID: 18441611
[TBL] [Abstract][Full Text] [Related]
8. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
Patel UD; Davis MM
J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
[TBL] [Abstract][Full Text] [Related]
9. Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada.
Contoyannis P; Hurley J; Grootendorst P; Jeon SH; Tamblyn R
Health Econ; 2005 Sep; 14(9):909-23. PubMed ID: 16127675
[TBL] [Abstract][Full Text] [Related]
10. The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer disease and related dementias.
Lin PJ; Biddle AK; Ganguly R; Kaufer DI; Maciejewski ML
Med Care; 2009 Nov; 47(11):1174-9. PubMed ID: 19786913
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in drug use and expenditures in a privately insured population of older adults.
Correa-de-Araujo R; Miller GE; Banthin JS; Trinh Y
J Womens Health (Larchmt); 2005; 14(1):73-81. PubMed ID: 15692281
[TBL] [Abstract][Full Text] [Related]
12. Incentive and selection effects of Medigap insurance on inpatient care.
Dardanoni V; Li Donni P
J Health Econ; 2012 May; 31(3):457-70. PubMed ID: 22525715
[TBL] [Abstract][Full Text] [Related]
13. Will the Medicare prescription drug benefit eliminate cost barriers for older adults with diabetes mellitus?
Tjia J; Schwartz JS
J Am Geriatr Soc; 2006 Apr; 54(4):606-12. PubMed ID: 16686870
[TBL] [Abstract][Full Text] [Related]
14. Assessment of drug consumption patterns for Medicare Part D patients.
Pedan A; Lu J; Varasteh LT
Am J Manag Care; 2009 May; 15(5):323-7. PubMed ID: 19435400
[TBL] [Abstract][Full Text] [Related]
15. Changes in drug utilization for seniors without prior prescription drug insurance.
Hudson N
Find Brief; 2009 Mar; 12(2):1-3. PubMed ID: 19297802
[TBL] [Abstract][Full Text] [Related]
16. Implications of the accuracy of MEPS prescription drug data for health services research.
Hill SC; Zuvekas SH; Zodet MW
Inquiry; 2011; 48(3):242-59. PubMed ID: 22235548
[TBL] [Abstract][Full Text] [Related]
17. The effect of longevity on spending for acute and long-term care.
Spillman BC; Lubitz J
N Engl J Med; 2000 May; 342(19):1409-15. PubMed ID: 10805827
[TBL] [Abstract][Full Text] [Related]
18. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
19. National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US.
Kim MH; Lin J; Kreilick C
Adv Ther; 2009 Aug; 26(8):784-94. PubMed ID: 19690820
[TBL] [Abstract][Full Text] [Related]
20. Cost minimization of medicare part D prescription drug plan expenditures.
Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR
Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
